Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures.

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63

Generic versus brand-name drugs used in cardiovascular diseases. Eur J Epidemiol (2015) 0.78

Comparative fasting bioavailability of two clopidogrel formulations in healthy Mediterranean volunteers: an in vitro-in vivo correlation. Drug Des Devel Ther (2015) 0.75

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med (2001) 20.20

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ (1994) 17.35

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (1996) 16.32

The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41

The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation (2000) 2.28

Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest (1991) 1.38

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb (1992) 1.16

Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost (1999) 1.08

ADP metabolism in vascular tissue, a possible thrombo-regulatory mechanism. Thromb Res (1979) 1.07

Repeated-dose pharmacodynamics of clopidogrel in healthy subjects. Semin Thromb Hemost (1999) 0.97

Single-dose pharmacodynamics of clopidogrel. Semin Thromb Hemost (1999) 0.93

Antiplatelet drugs. A comparative review. Drugs (1995) 0.92

ADP plays a key role in thrombogenesis in rats. Thromb Haemost (1988) 0.90

ADP receptors on platelets and ADP-selective antiaggregating agents. Med Res Rev (1996) 0.86

Non-invasive measurement of aortic pressure in patients: Comparing pulse wave analysis and applanation tonometry. Indian J Pharmacol (2012) 0.81